Patent Application
20080063695
Various embodiments of the present disclosure will be described herein below with reference to the figures wherein:
The dressings of the present disclosure possess various layers, in embodiments more than one layer. The dressings may include, in embodiments, a hydrophilic layer with a hydrophobic layer.
Suitable hydrophilic layers which may be utilized to produce a dressing of the present disclosure include hydrophilic thermoplastic materials having a high moisture vapor transmission rate (“MVTR”) from about 400 gr/m2/24-hours to about 3000 gr/m2/24-hours, in embodiments from about 500 gr/m2/24-hours to about 2000 gr/m2/24-hours. Such materials are within the purview of those skilled in the art and include, in embodiments, from about 5% to about 95% by weight water when hydrated, in embodiments from about 10% to about 50% by weight water when hydrated, in other embodiments from about 20% to about 40% by weight water when hydrated. Suitable hydrophilic materials include polymers such as cross-linked polyvinyl alcohol, cross-linked polyvinyl pyrrolidone, hydrophilic polyurethanes, hydrophilic hydroxyalkyl esters of poly(meth)acrylic acid and copolymers thereof, hydrophilic polyether-polyamide polymers, hydrophilic and water insoluble cellulosic derivatives such as cellulose acetate and cellulose acetate-propionate, as well as combinations of the foregoing.
Cross-linked polymers which may be utilized as the hydrophilic material may be cross-linked during the polymerization reaction or afterwards using a polyfunctional group such as a polyisocyanate.
In some embodiments, the hydrophilic layer may include a hydrophilic polymer such as cross-linked and/or linear hydrophilic polyurethanes. In embodiments, suitable hydrophilic materials include thermoplastic polyurethanes. Specific polyurethanes which may be utilized to form the hydrophilic layer include linear polyether polyurethanes formed from polyethylene glycol, polypropylene glycol, or combinations thereof with a diisocyanate and optionally an ethanediol or ethylene diamine as chain extender. Other hydrophilic polyurethanes which may be utilized include, for example, polyether thermoplastic polyurethanes including those derived from aromatic diisocyanates such as DUREFLEX® RPT1700S (available from Deerfield Urethane).
This first hydrophilic layer of a dressing of the present disclosure may have a thickness from about 0.4 mils to about 1.5 mils, in embodiments from about 0.6 mils to about 1 mils, with a thickness of about 0.8 mils being utilized in some embodiments. In embodiments, the first hydrophilic layer may include a monolithic, aromatic, thermoplastic polyurethane film. Such materials may be advantageously used in a dressing of the present disclosure adjacent a skin break or wound site, as monolithic films are excellent viral and bacterial barriers at thicknesses greater than or equal to about 0.4 mils.
In embodiments the first layer may possess a coating. The coating may be found on any portion of the layer or, in some embodiments, may be on the side of the layer which will be placed adjacent a patient's skin. Suitable coatings are within the purview of those skilled in the art and include, for example, an adhesive such as a medical grade adhesive or a hydrogel. Suitable adhesives include any pressure sensitive adhesive which is medically accepted and skin friendly, including acrylic, hydrocolloid, hydrogel, polyurethane and silicone based adhesives, as well as combinations thereof.
Any coating may be applied to the hydrophilic layer utilizing means within the purview of those skilled in the art and may be continuous, semi-continuous, non-continuous, and the like. Thus, in embodiments, the coating may be an adhesive selected and applied so that the first hydrophilic layer has a desired level of adhesion to skin and MVTR.
In embodiments, it may be advantageous for the hydrophilic layer, and any coating applied thereto, including a hydrogel or adhesive, to be transparent.
The second layer of a dressing of the present disclosure includes a hydrophobic layer or film. Suitable hydrophobic layers may have a moisture vapor transmission rate (“MVTR”) from about 250 gr/m2/24-hours to about 1000 gr/m2/24-hours, in embodiments from about 400 gr/m2/24-hours to about 750 gr/m2/24-hours. Suitable materials to use as the hydrophobic layer or film are within the purview of those skilled in the art and include, for example, breathable olefins, elastomeric co-polyesters, and urethanes. Specific examples of suitable hydrophobic materials include aromatic polyester urethanes such as DUREFLEX® U04 (from Deerfield Urethane). This second hydrophobic layer may have a thickness from about 0.4 mils to about 5 mils, in embodiments from about 1 mils to about 4 mils.
In embodiments, the hydrophobic layer may be centered over the first hydrophilic layer and may be larger than the first layer so that the perimeter of the hydrophobic layer may form a uniform extended flange around and extending beyond the outer edge of the first hydrophilic layer. This construction may permit the use of an adhesive onto the extended flange portion of the hydrophobic layer to promote secure perimeter adherence upon application of a dressing of the present disclosure to skin. In other embodiments, the hydrophobic layer may be placed over the hydrophilic layer so that the hydrophobic layer is not centered, but rather off-set to one or more sides of the dressing.
In embodiments, the length of the extended flange, that is, the length by which the perimeter of the hydrophobic layer extends beyond the perimeter of the hydrophilic layer, may be from about 1/32 inch to about ¾ inch, in embodiments from about 1/16 inch to about ½ inch, with ¼ inch being utilized in some embodiments. In embodiments, the extended flange of the hydrophobic layer may possess any adhesive described above on the side adjacent the patient's skin to enhance adherence of a dressing of the present disclosure to tissue.
In embodiments, the central portion of the hydrophobic layer may be removed, thereby forming a window in the dressing of the present disclosure. The removal of a central portion of the hydrophobic layer may result in the formation of an inside edge within the hydrophobic layer which should be from about 1/16 inch to about ¾ inch from the outer perimeter of the hydrophilic layer, in embodiments from about ⅛ inch to about 1/2 inch from the outer edge of the first hydrophilic layer.
The removal of a central portion of the hydrophobic layer may assist a dressing of the present disclosure in maintaining a desired level of flexibility, conformability, and MVTR. Moreover, such a window, when utilized with a transparent hydrophilic layer, would permit viewing of a wound site to which the dressing of the present disclosure has been applied.
Dressings of the present disclosure may possess additional optional layers. For example, in embodiments, a release layer may be applied to the hydrophilic layer and any adhesive coating thereon to protect the adhesive layer. In embodiments, such a release layer may also cover the portion of the hydrophobic layer extending beyond the edge of the hydrophilic layer; such a covering may be especially useful where the portion of the hydrophobic layer extending beyond the edge of the hydrophilic layer possesses an adhesive thereon. Any release layer commercially available and/or within the purview of those skilled in the art may be utilized.
In embodiments, a third layer may be applied to the hydrophobic layer of a dressing of the present disclosure. Such a layer may, in embodiments, be non-breathable and hydrophobic. Such a layer, in embodiments referred to as a delivery layer, may be utilized to provide a means for single-handed, wrinkle free application of a dressing of the present disclosure. Suitable materials which may be utilized to form this delivery layer include thermal plastic films including, but not limited to, olefins, polyesters, copolymers thereof and combinations thereof. In embodiments, a polyethylene/ethylene vinyl acetate (EVA) blend may be utilized as the delivery layer. Other materials which may be utilized to form this delivery layer include monolayer metallocene films, which may have a smooth or matte surface finish, and polyethylene/vinyl acetate copolymer-coated super calendered bleached kraft (commercially available as 1-80BKG-157 from Loparex, Inc., or similar materials).
In embodiments, the hydrophobic layer may be devoid of fillers and other processing aids sometimes utilized in conventional dressings. Such fillers and processing aids may inhibit the ability of the hydrophobic layer to bond to the delivery layer.
Methods for attaching the hydrophilic layer to the hydrophobic layer and, similarly, attaching the delivery layer to the hydrophobic layer are within the purview of those skilled in the art and include, for example, thermal bonding processes. In embodiments the thermal bonding process may include heating the hydrophilic/hydrophobic combination of layers to a temperature from about 240° F. to about 343° F., in embodiments from about 245° F. to about 265° F., for a period of time from about 0.125 seconds to about 0.025 seconds, in embodiments from about 0.05 seconds to about 0.035 seconds. This heating process may result in the thermal bonding of the hydrophilic layer to the hydrophobic layer. Similarly, bonding of the delivery layer may be accomplished by heating the hydrophobic layer or hydrophilic/hydrophobic combination of layers and the delivery layer to a temperature from about 225° F. to about 300° F., in embodiments from about 260° F. to 280° F., for a period of time from about 0.45 seconds to about 0.0025 seconds, in embodiments from about 0.225 seconds to about 0.003 seconds.
The heating of the various layers utilized to form a dressing of the present disclosure may use a plurality of heated rolls, with at least two arranged to provide compressive forces to attain bonding. In embodiments, it may be desirable that at least one of the rolls be covered with a soft thermally stable surface, in embodiments a silicone rubber, though other materials within the purview of those skilled in the art may be utilized. It is envisioned that the soft surface could have a durometer (surface hardness), from about 40 shore A to about 100 shore A, in embodiments from about 60 shore A to about 80 shore A, with a durometer of about 70 shore A being utilized in some embodiments.
The delivery layer may, in embodiments, possess a size and shape comparable to that of the hydrophobic layer and, in embodiments, may cover the entire area of both the hydrophilic layer and the hydrophobic layer. In embodiments, a central portion of the delivery layer may also be removed. The central portion of the delivery layer which is removed may be of any shape; in embodiments, the dimensions of the central portion removed from the delivery layer are similar to the dimensions of the portion removed from the hydrophobic layer, i.e., the window described above. In some embodiments the shape and dimension of the central portion removed from the delivery layer may be identical to the shape and dimension of the central portion removed from the hydrophobic layer so that the window formed in the delivery layer is contiguous with the window formed in the hydrophobic layer.
In embodiments an additional fourth layer may be utilized in a dressing of the present disclosure. Such a layer may, in embodiments, be constructed of a nonwoven material, in embodiments a cellulosic material. This fourth layer may be coated on one of its sides with a suitable adhesive, including those adhesives described above for use on the hydrophilic layer and/or the hydrophobic layer and may, in embodiments, be referred to as an adhesive tape. This fourth layer may be positioned between the delivery layer and the hydrophobic layer so that the side possessing the adhesive is adjacent the delivery layer and the side lacking adhesive is in contact with the hydrophobic layer. This layer may, in embodiments, be positioned along one edge of the delivery layer, such that its outer edge is coextensive with the outer edge of the delivery layer (as noted above, the outer edge of the delivery layer may extend beyond the outer edge of the hydrophobic layer). The inner edge of the fourth layer may, in embodiments, overlap the outer edge of the hydrophobic layer by at least about 1/16 of an inch. The amount of overlap may vary, in embodiments from about 1/16 inch to about ½ inch, in embodiments from about ⅛ inch to about ¼ inch.
Where present, the fourth layer may serve several purposes. In embodiments, the fourth layer may facilitate the removal of the delivery layer from the hydrophobic layer upon application of a dressing of the present disclosure, by providing an initial disruption of the surface bond between the delivery layer and the hydrophobic layer and providing a means to grasp thereby facilitating separation of the delivery layer from the hydrophobic layer via peeling. Moreover, in embodiments, the fourth layer may be separated from the delivery layer via peeling at which time it may function as a change documentation tool, i.e., its presence may be utilized as evidence of a change of dressings or, in embodiments, notations including the date and time of application of the dressing may be placed on the fourth layer after removal, which may be retained as evidence of the change of the dressing. Moreover, the fourth layer could be further adapted to better facilitate the peel of said layer by applying any adhesive to the fourth layer in a manner to provide a non-coated edge or edges. In other embodiments, the inboard edge of the fourth layer may be folded over onto the adhesive side of the fourth layer. This would produce a non-adhered flap to facilitate removal. In yet other embodiments, the fourth layer may be subjected to a controlled depth die cutting process that would cut any protective release liner attached to the adhesive on the fourth layer prior to its attachment to the third layer. The cut would allow a portion of the release liner to remain while the balance is removed. The remaining portion would provide a non-adhered flap that would facilitate tape peel.
Dressings of the present disclosure may possess varying geometries and configurations. In addition, in embodiments, notches, slits, clearance holes, and similar perimeter modifications may be made to a dressing of the present disclosure at one or more locations of the perimeter of a dressing to facilitate the use of a dressing of the present disclosure with various other medical devices, including ported and non-ported intravenous needles and similar devices which may be utilized in short peripheral intravenous applications. Where present, it may be advantageous for the various layers of a dressing of the present disclosure to possess a notch, etc. in the same location so that the notches of the various layers are contiguous and result in a dressing possessing a notch in one location thereon.
In yet other embodiments, an additional layer may be applied to a dressing of the present disclosure between the hydrophilic layer and the hydrophobic layer. Such a layer may be utilized to further stabilize a dressing of the present disclosure and provide additional structure thereto and may be referred to, in embodiments, as a stabilizer layer. Such stabilization may be desirable for various procedures, including the use of a dressing of the present disclosure in conjunction with central venous catheters (CVC), dialysis, and/or pulmonary artery (PA) catheters. Where utilized, this additional stabilizer layer may be placed between the hydrophilic layer and the hydrophobic layer, in embodiments at the periphery of the hydrophobic layer and hydrophilic layer where modifications such as notches, slits, and the like may be present. A stabilizer layer may be constructed of appropriate materials within the purview of those skilled in the art capable of providing the desired structure and rigidity to a dressing of the present disclosure. Both woven and non-woven materials are contemplated, including gauze, cloth, thermal bonded polypropylene, spunbonded polyproplene, nylon (CEREX™), hydroentangled polyester (SONTARA™), nonwoven cellulosic acetate, woven taffeta acetate, and combinations thereof.
Where present, the stabilizer layer may possess thereon any adhesive coating described above as suitable for any other layer of a dressing of the present disclosure, to facilitate its application and adherence to the hydrophobic layer and/or the hydrophilic layer. The strength of any adhesive applied to the stabilizer layer should be, at a minimum, equivalent to the strength of any adhesive utilized to adhere the hydrophobic layer to the hydrophilic layer. The stabilizer layer may, in embodiments, provide a rigid construction to assist in keeping any catheter and/or intravenous line from moving excessively. This may be beneficial as excessive movement of a catheter or intravenous line may cause both patient discomfort and other complications.
A stabilizer layer may possess a configuration similar to the hydrophobic layer, i.e., with a window removed from a central portion thereof. In other embodiments, a stabilizer layer may possess a strip configuration and may be located at one side of the hydrophilic layer and hydrophobic layer at the perimeter of these two layers.
In yet other embodiments, a dressing of the present disclosure may include an absorbent material. The absorbent material may be included as a component of any other layer of the dressing of the present disclosure or may be included as a separate layer of a dressing of the present disclosure. In some embodiments, it may be advantageous for the hydrophilic layer of the present disclosure to possess an absorbent material. Such an absorbent material may be applied to any locus of the hydrophilic layer, but typically is present in the surface plane of the hydrophilic layer. As described above, in embodiments the absorbent material may be applied to the hydrophilic layer as a separate absorbent layer. In other embodiments, the absorbent material may be located at the perimeter of the hydrophilic layer, for example, by being applied only to the perimeter of the hydrophilic layer, or where utilized as a separate layer, by having a central portion removed therefrom thereby forming a window in the absorbent layer similar to the window which may be present in the other layers as described above.
The absorbent material may help control minor leakage at the wound site, or at the site of insertion of a needle, depending upon the circumstances of the application of a dressing of the present disclosure. The ability to absorb such fluids may extend the life of the dressing by minimizing the deterioration of the dressing or any component thereof, including adhesives, which may otherwise occur in the presence of body fluids including any wound exudate. Suitable materials which may be utilized as the absorbent material include those currently utilized with dressings and/or the treatment of wounds including, for example, cotton, alginate, rayon, cellulose, urethanes, hydrogels, hydrocolloids, polyethylene oxides, and superabsorbent polymers such as sodium and aluminum salts of starch grafted copolymers of acrylates and acrylamides, combinations thereof, as well as polyacrylate salts. In some embodiments, superabsorbent polymers which may be utilized include hydrophilic cellulose derivatives that have been partially cross-linked to form a three dimensional structure. Suitable cross-linked cellulose derivatives include those of the hydroxy lower alkyl celluloses, wherein the alkyl group contains from about 1 to about 6 carbon atoms, for example, hydroxyethyl cellulose or hydroxypropylcellulose, or the carboxy-celluloses such as, for example, carboxymethyl hydroxyethyl cellulose or carboxy methylcellulose. Salts of such polymers, for example a partially cross-linked sodium carboxy methylcellulose polymer, may be utilized in embodiments.
Other absorbent materials which can be used include methylcellulose, guar gum, pectin, karaya gum, chitosan, agar, acacia powder, carrageenan, gelatin and combinations thereof. The absorbent material may be in any suitable form including, but not limited to, woven or nonwoven webs, fibers, powders, pastes, foams, gels, or any other form that may be incorporated in another layer or applied as a separate absorbent layer in forming a dressing of the present disclosure. In embodiments, the absorbent material may possess natural antimicrobial properties.
Dressings of the present disclosure may possess any configuration, which may be adjusted depending upon the desired use of the dressing and the par of the body to which the dressing is to be applied.
In other embodiments, a tape may be utilized to further assist in attaching a dressing of the present disclosure to a patient. Such tapes are within the purview of those skilled in the art and are commercially available. Any medically acceptable tape utilized to adhere dressings to a patient may be utilized.
Dressings of the present disclosure have a thinner profile than conventional dressings. A dressing of the present disclosure may have a thickness from about 3 mils to about 11 mils, in embodiments from about 4.6 mils to about 7 mils.
Turning now to the figures, various configurations of dressings of the present disclosure are described. As set forth in
Another dressing of the present disclosure is set forth in
The dressing of
The dressing of
The present disclosure also relates to the use of dressings according to the present disclosure in medicine, for example, as wound dressings, bandages or supports.
Dressings of the present disclosure may contain, if desired, one or more medicinal agents. In embodiments, such medicinal agents may elute from the dressing of the present disclosure at the site of application. As used herein, “medicinal agent” is used in its broadest sense and includes any substance or mixture of substances that have clinical use. Consequently, medicinal agents may or may not have pharmacological activity per se, e.g., a dye. Examples of classes of medicinal agents which may be combined or mixed into the foam of the present disclosure include antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistamines, anti-inflammatories, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hormones, growth factors, muscle relaxants, antineoplastics, immunosuppressants, steroids, polysaccharides, and enzymes. It is also intended that combinations of medicinal agents may be used.
Suitable antimicrobial agents which may be included as a medicinal agent in the dressings of the present disclosure include triclosan, also known as 2,4,4′-trichloro-2′-hydroxydiphenyl ether, biguanides including polyhexamethylne biguanide and chlorhexidine and its salts, including chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine hydrochloride, and chlorhexidine sulfate, silver and its salts, including silver acetate, silver benzoate, silver carbonate, silver citrate, silver iodate, silver iodide, silver lactate, silver laurate, silver nitrate, silver oxide, silver palmitate, silver protein, and silver sulfadiazine, polymyxin, tetracycline, aminoglycosides, such as tobramycin and gentamicin, rifampicin, bacitracin, neomycin, chloramphenicol, miconazole, quinolones such as oxolinic acid, norfloxacin, nalidixic acid, pefloxacin, enoxacin and ciprofloxacin, penicillins such as oxacillin and pipracil, nonoxynol 9, fusidic acid, cephalosporins, and combinations thereof. In addition, antimicrobial proteins and peptides such as bovine lactoferrin and lactoferricin B may be included as a medicinal agent in the dressings of the present disclosure.
Other medicinal agents which may be included as a medicinal agent in the dressings of the present disclosure include: local anesthetics; parasympathomimetic agents; tranquilizers; sulfonamides; vitamins; antimalarials; anti-migraine agents; anti-parkinson agents such as L-dopa; anti-spasmodics; anticholinergic agents (e.g. oxybutynin); cardiovascular agents such as coronary vasodilators and nitroglycerin; alkaloids; analgesics; narcotics such as codeine, dihydrocodeinone, meperidine, morphine and the like; non-narcotics such as salicylates, aspirin, acetaminophen, d-propoxyphene and the like; opioid receptor antagonists, such as naltrexone and naloxone; anti-cancer agents; anti-convulsants; anti-emetics; antihistamines; anti-inflammatory agents such as hormonal agents, hydrocortisone, prednisolone, prednisone, non-hormonal agents, allopurinol, indomethacin, phenylbutazone and the like; prostaglandins and cytotoxic drugs; estrogens; antibacterials; antifungals; antivirals; anticoagulants; anticonvulsants; antidepressants; immunological agents; hormones and hormone analogs (e.g., growth hormone, adrenocorticotropic hormone and luteinizing hormone releasing hormone (LHRH)); vaccines (e.g., tumoral, bacterial and viral antigens); somatostatin; antigens; blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein antagonists, and protein agonists; nucleic acids, such as antisense molecules, DNA and RNA; oligonucleotides; and ribozymes. As noted above, in embodiments combinations of medicinal agents may be utilized.
The amount of medicinal agent present will depend upon the particular medicinal agent chosen, but may be in an amount from about 10 parts per million (ppm) to about 10,000 ppm.
While medicinal agents may be incorporated in or applied to any layer utilized to form a dressing of the present disclosure, in embodiments the medicinal agents may be applied to those layers and/or components which come into contact with a patient's skin. Such layers include, for example, the hydrophilic layer, adhesive layers applied thereto, and/or to the periphery of the hydrophobic layer, and any absorbent material included in the surface plane or at the periphery of the hydrophilic layer, or applied to the hydrophilic layer as a separate absorbent layer.
Medicinal agent(s) or other additives may be incorporated into a dressing of the present disclosure by any method within the purview of those skilled in the art. In embodiments, the agent(s) or other additives may be incorporated into the dressing by addition of agent(s) or other additives into the materials utilized in forming the layers of the dressing before reacting and forming the material utilized to form the specific layer. In other embodiments, the agent(s) or other additives may be incorporated into the dressing by separately introducing the agent(s) or additives as the various layers of a dressing of the present disclosure are combined. In yet other embodiments, the agent(s) or other additives may be incorporated into the dressing by a padding process after the dressing is formed, for example by applying the agent(s) or additives to the dressing or any layer thereof by saturating the dressing or layer in a trough or similar vessel and then squeezing the saturated dressing or layer through pressure rollers to achieve a uniform application of the agent(s) or additives and incorporation of the agent(s) and/or additives both upon the surface of the dressing and/or layer or within the dressing or layer itself.
In yet other embodiments, agent(s) or other additives may be applied as a coating to the dressings of the present disclosure, either by separate application of said agent(s) or other additives in a solvent and then evaporating the solvent or by their inclusion in an additional layer utilized to form a dressing of the present disclosure. Such layers include any additional layers such as backing layers, including polyurethane backing layers, or any additional nonwoven layer, fibrous layer, or adhesive utilized in combination with a dressing of the present disclosure. In embodiments, agent(s) or additives may be included in a separate coating applied to a dressing of the present disclosure. Such coatings may be made of any biocompatible material, including both natural and synthetic polymers, copolymers, hydrogels, and the like. Such coatings may also be applied to any backing layer, adhesive layer, or any other layer of a dressing of the present disclosure.
In embodiments, coating materials may include peptides or proteins including, but not limited to, albumin, collagen, fibrin, elastin and the like. Other coating materials which may be utilized include polysaccharides such as chitosan, alginate, hyaluronic acid and the like. In other embodiments, synthetic polymers may be utilized as the coating material. Such polymers include, for example, polyesters, polyethers, polycarbonates, and polyanhydrides. Suitable polyesters which may be utilized are within the purview of those skilled in the art and include, for example, trimethylene carbonate, ε-caprolactone, p-dioxanone, glycolide, lactide, 1,5-dioxepan-2-one, polybutylene adipate, polyethylene adipate, polyethylene terephthalate, and homopolymers and copolymers thereof. Suitable polyethers which may be utilized are within the purview of those skilled in the art and include, for example, polyethylene glycol, polypropylene glycol, polybutylene glycol, polytetramethylene glycol, polyhexamethylene glycol, homopolymers thereof and copolymers thereof. Suitable polycarbonates include, for example, tetramethylene carbonates, trimethylene carbonates, pentamethylene carbonates, homopolymers thereof, copolymers thereof, and the like.
Dressings of the present disclosure possess several advantages compared with conventional dressings. They may be applied with only one hand, and undergo minimal wrinkling, which is of great advantage to any medical personnel utilizing such dressings. They provide maximum MVTR to the wound/insertion area. They minimize the need for the use of additional skin adhesives and may be constructed so that the perimeter has greater adhesion, thereby reducing or preventing lift of the dressing. The lower degree of adhesion at the wound/insertion area minimizes wound trauma or catheter removal at dressing change, and any adhesive used thereon could be replaced with a hydrogel which, in embodiments, could possess a medicinal agent such as an antimicrobial. In other embodiments, if the hydrophilic layer is constructed of a transparent material, the wound/insertion site may be easily inspected without the need for removing the dressing of the present disclosure.
It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of useful embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
This application claims the benefit of U.S. Provisional Patent Application No. 60/844,008, filed Sep. 12, 2006, the entire disclosure of which is incorporated by reference herein.
| Number | Date | Country | |
|---|---|---|---|
| 60844008 | Sep 2006 | US |
